These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 8473656

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of amrinone on the right side of the heart.
    Hess W.
    J Cardiothorac Anesth; 1989 Dec; 3(6 Suppl 2):38-44. PubMed ID: 2521050
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacologic reduction of pretransplantation pulmonary vascular resistance predicts outcome after pediatric heart transplantation.
    Zales VR, Pahl E, Backer CL, Crawford S, Mavroudis C, Benson DW.
    J Heart Lung Transplant; 1993 Dec; 12(6 Pt 1):965-72; discussion 972-3. PubMed ID: 8312321
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hemodynamic effects of hydralazine in infants with a large ventricular septal defect.
    Beekman RH, Rocchini AP, Rosenthal A.
    Circulation; 1982 Mar; 65(3):523-8. PubMed ID: 6459891
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term outcome of patients operated for large ventricular septal defects with increased pulmonary vascular resistance.
    Kannan BR, Sivasankaran S, Tharakan JA, Titus T, Ajith Kumar VK, Francis B, Krishnamoorthy KM, Harikrishnan S, Padmakumar R, Nair K.
    Indian Heart J; 2003 Mar; 55(2):161-6. PubMed ID: 12921332
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy of nitroglycerin inhalation in reducing pulmonary arterial hypertension in children with congenital heart disease.
    Goyal P, Kiran U, Chauhan S, Juneja R, Choudhary M.
    Br J Anaesth; 2006 Aug; 97(2):208-14. PubMed ID: 16707530
    [Abstract] [Full Text] [Related]

  • 16. The haemodynamic effects of amrinone in patients with mitral stenosis and pulmonary hypertension.
    Hess W, Arnold B, Veit S.
    Eur Heart J; 1986 Sep; 7(9):800-7. PubMed ID: 3769960
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hemodynamic effects of nitroprusside in infants with a large ventricular septal defect.
    Beekman RH, Rocchini AP, Rosenthal A.
    Circulation; 1981 Sep; 64(3):553-8. PubMed ID: 7261287
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Functional studies in rest and during exertion in children and adolescents with ventricular septal defects and pulmonary hypertension].
    Mocellin R, Friedman J, Sebening W, Bühlmeyer K.
    Z Kardiol; 1975 Nov; 64(11):1036-52. PubMed ID: 1210513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.